Literature DB >> 3540249

Group B streptococcal carriage and disease: a 6-year prospective study.

H C Dillon, S Khare, B M Gray.   

Abstract

A prospective study of group B streptococcal (GBS) carriage and disease was conducted over 6 years. Carriage rates at delivery for mothers and infants were 20% and 12%, respectively. Forty-five cases of GBS disease occurred in infants, 24 "early-onset" disease and 21 "late-onset" disease. The combined attack rate for early and late disease was 3.3 per 1000 live births over the 6 years. The rate of early-onset disease was highest in infants found to be heavily colonized at birth: 50 per 1000 live births. Twenty-three of 24 had evidence of intrauterine-acquired infection. All GBS serotypes were represented. Preterm delivery, prolonged labor, premature rupture of membranes, and maternal infection enhanced the risk of early disease. Septicemia was the predominant form of late-onset disease (15 of 21 cases); GBS type III accounted for 19 of 21 cases. Ten of 21 infants with late infections were colonized at birth with the GBS type that subsequently caused disease. Thus a maternal source of infection was identified in 34 of the 45 infants. These data reveal consistent year-to-year carriage and disease rates in the study population.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3540249     DOI: 10.1016/s0022-3476(87)80283-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

1.  Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

2.  Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis.

Authors:  K Rolland; C Marois; V Siquier; B Cattier; R Quentin
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

4.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study.

Authors:  Feng-Ying C Lin; April Whiting; Elisabeth Adderson; Shinji Takahashi; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; Joan Regan; Penny Clark; George G Rhoads; Carl E Frasch; James Troendle; Patricia Moyer; John F Bohnsack
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Authors:  John F Bohnsack; April Whiting; Marcelo Gottschalk; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; George G Rhoads; Feng-Ying C Lin
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

7.  Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital.

Authors:  Y Uh; I H Jang; K J Yoon; C H Lee; J Y Kwon; M C Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

Review 8.  Neonatal infections: group B streptococcus.

Authors:  Paul T Heath; Luke Anthony Jardine
Journal:  BMJ Clin Evid       Date:  2014-02-28

9.  Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease.

Authors:  M Hauge; C Jespersgaard; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.